Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
Steigende Produktionsmengen, operative Hebelwirkung und der Goldpreis könnten zusammen neue Impulse setzen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
1.017 Leser
Artikel bewerten:
(2)

bioMDplus: CBD Oil for Anxiety: What is the Best CBD Oil as an Alternative to Prescription Drugs?

BROOKLYN, NY / ACCESSWIRE / March 5, 2020 / With so many CBD products on the market, consumers are often unsure of effective products to buy. A leading CBD resource, bioMD+, recently published an article titled "CBD Oil for Anxiety" in which they highlight relevant CBD research in this area and make recommendations for the top CBD oil for anxiety.

Read it here: https://biomdplus.com/cbd-oil-for-anxiety/.

BioMD+ is the top-rated company is based in Marietta, Georgia and has become a new standard for effectiveness and transparency in the CBD industry. The article explains how bioMD+ earned this reputation through its commitment to quality.

BioMD+ uses nothing but Organic Colorado-Grown hemp and enhances each of their hemp oil products with a blend of natural terpenes design for maximum support for the effectiveness of the cannabinoids.

Their CBD Oils are refined through a Supercritical C02 extraction process and then further purified into Winterized oil--a step which few other companies seek in efforts to cut costs. In each of their different CBD oil products contain 1,000mg of potent CBD per bottle, and lab results made directly available so the customer knows exactly what they are buying.

The legal landscape of CBD remains complex because of differing state and federal laws giving access to medical hemp and marijuana products.

As an effective alternative to the items most commonly found in medicine cabinets today. We accomplish this by always:

  • Striving to responsibly educate consumers on the benefits of hemp

  • Allow science to lead our product development

  • Utilize only the highest quality 100% USA grown hemp in all of our products

The passage of the Farm Bill in December 2018 opened the door for millions of Americans to have easier access to CBD and other cannabinoids as a health supplement.

By removing hemp from the Controlled Substances Act, the Farm Bill paved the way for the legal cultivation, possession, sale, and distribution of the hemp plant allowing companies like us to bring professionalism to the industry and bring the benefits of hemp-derived CBD to the masses.

CBD is a huge emerging market. The industry has been growing rapidly and is projected to be worth $22 billion by 2022. According to Consumer Reports, 64 million Americans have tried CBD in just the past two years alone.

CBD, which is short for cannabidiol, is one of the chemical compounds found in cannabis and hemp plants. Preliminary research and years of anecdotal evidence have pointed to the many promising health benefits of CBD.

One area of benefits, in particular, has received a lot of attention, and that is CBD oils use for anxiety and depression relief. CBD's ability to aid in the reduction and management of anxiety has been demonstrated in research studies and lauded by celebrities including Jennifer Aniston and supermodel Alessandra Ambrosio who report using CBD to help manage anxiety.

In a 2019 study published in The Permanente Journal, researchers reported that "anxiety scores decreased within the first month in 79.2% of the 57 patients and remained decreased during the study duration."

CONTACT:
Azriel Adelberg
Brooklyn, NY
470-433-3362
support@biomdplus.com

SOURCE: bioMDplus



View source version on accesswire.com:
https://www.accesswire.com/579231/CBD-Oil-for-Anxiety-What-is-the-Best-CBD-Oil-as-an-Alternative-to-Prescription-Drugs

© 2020 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.